In patients with T2D, the strong β-cell resistance to GIP and a slight resistance to GLP-1 could be secondary to glucotoxicity (57) due to a down regulation of their receptors induced by hyperglycemia (37,67). Here, GIP is linked to type 2 diabetes mellitus.